May 16, 2025

Delandistrogene Moxeparvovec: Efficacy Evidence Questioned

The AAN Guidelines Subcommittee review finds delandistrogene moxeparvovec for DMD failed to meet primary functional outcomes despite FDA approval.

Conexiant

May 15, 2025

Assistant Professor Salary Gaps Persist Nationwide

Persistent salary disparities by gender, race, and ethnicity were identified among more than 45,000 U.S. assistant professors, with underrepresented in medicine women learning the least across all specialties.

Conexiant

May 14, 2025

Leading Cause of Death in Residents, Study

Study shows high suicide rates during training transitions, with pathology residents facing the highest suicide risk compared with other specialties.

Conexiant

May 12, 2025

Radiocontrast Agent Found Safe for TTP Testing

A new in vitro study found that iodinated contrast media do not interfere with ADAMTS13 activity testing, even at high concentrations or after light exposure, supporting uninterrupted diagnostic testing for thrombotic thrombocytopenic purpura.

Conexiant

May 09, 2025

BAL Guides Treatment in Pediatric Respiratory Illness

BAL detected pathogens in 61% of cases and led to treatment changes in nearly 9 out of 10 immunocompromised children with acute respiratory illness, according to a new 5-year study.

Conexiant

April 28, 2025

Could a New Urine Test Detect Prostate Cancer? 

Researchers combined spatial transcriptomics with machine learning to develop a urine-based prostate cancer test with 92% accuracy, outperforming traditional PSA testing.

Conexiant

April 23, 2025

Sense of Belonging 'Critical' for Workplace Retention

Individuals who reported a neutral level of satisfaction with their sense of belonging were approximately 3 times more likely to express an intent to leave, while those who were dissatisfied were 7 times more likely to do so, compared to individuals who were satisfied with their sense of belonging.

Conexiant

April 22, 2025

Heavy Metals Found in Toothpaste

There are some "heavy metals that are essential in small quantities but could result in adverse effects if present in excess."

Conexiant

April 21, 2025

Transfusion Strategy Outcomes After Aneurysmal SAH Similar, Study Reveals

SAHaRA trial investigators compared a liberal (transfusion at hemoglobin levels of 10 g/dL or lower) and a restrictive (transfusion at 8 g/dL or lower) red-cell tranfusion strategy among critically ill patients with acute aneurysmal subarachnoid hemorrhage (SAH) and anemia.

Conexiant